Charles Schwab’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $21.5M | Buy |
|
|||||
|
2023
Q3 | $15M | Sell |
|
|||||
|
2023
Q2 | $15.8M | Buy |
|
|||||
|
2023
Q1 | $16M | Sell |
|
|||||
|
2022
Q4 | $19.6M | Buy |
|
|||||
|
2022
Q3 | $28.2M | Buy |
|
|||||
|
2022
Q2 | $26.4M | Sell |
|
|||||
|
2022
Q1 | $32.3M | Buy |
|
|||||
|
2021
Q4 | $56.1M | Buy |
|
|||||
|
2021
Q3 | $61.4M | Buy |
|
|||||
|
2021
Q2 | $55.3M | Sell |
|
|||||
|
2021
Q1 | $71.4M | Buy |
|
|||||
|
2020
Q4 | $89.1M | Buy |
|
|||||
|
2020
Q3 | $57.8M | Buy |
|
|||||
|
2020
Q2 | $29.8M | Buy |
|
|||||
|
2020
Q1 | $17.5M | Buy |
|
|||||
|
2019
Q4 | $25.1M | Buy |
|
|||||
|
2019
Q3 | $14.8M | Buy |
|
|||||
|
2019
Q2 | $18.6M | Buy |
|
|||||
|
2019
Q1 | $12.4M | Buy |
|
|||||
|
2018
Q4 | $6.5M | Sell |
|
|||||
|
2018
Q3 | $7.26M | Buy |
|
|||||
|
2018
Q2 | $2.13M | Buy |
|
|||||
|
2018
Q1 | $239K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $103K | Buy |
|
|||||
|
2016
Q4 | $86K | Hold |
|
|||||
|
2016
Q3 | $120K | Hold |
|
|||||
|
2016
Q2 | $99K | Hold |
|
|||||
|
2016
Q1 | $387K | Hold |
|
|||||
|
2015
Q4 | $571K | Buy |
|
|||||
|
2015
Q3 | $491K | Hold |
|
|||||
|
2015
Q2 | $449K | Buy |
|
|||||
|
2015
Q1 | $308K | Hold |
|
|||||
|
2014
Q4 | $195K | Hold |
|
|||||
|
2014
Q3 | $184K | Hold |
|
|||||
|
2014
Q2 | $210K | Buy |
|